Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1,000,000.0 | $3.5M | 0.14% | NEW | — | $3.51 | +17.1% |
| 22 | MSLE | SATELLOS BIOSCIENCE INC | Healthcare | 414,359.0 | $2.3M | 0.09% | NEW | — | $5.63 | +19.9% |
| 23 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 28,479.0 | $1.8M | 0.07% | NEW | — | $62.70 | +19.5% |
| 24 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 300,000.0 | $1.4M | 0.06% | NEW | — | $4.70 | -20.0% |
| 25 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 10,000.0 | $313K | 0.01% | NEW | — | $31.29 | +20.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%